Investor type Venture Capital
Founders Petr Sramek


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 31
Average round size
The average size of a deal this fund participated in
Portfolio companies 29
Rounds per year 15.50
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Artificial Intelligence
  • Health Diagnostics
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Longevitytech.fund:
Typical Co-investors
Longevitytech.fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Longevitytech.fund:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Czechia
Funds with similar focus located in Czechia:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Amherst Holdings Austin, Texas, United States
Anschutz Investment Colorado, Denver, United States
Bharti Soft Bank Belmont, Massachusetts, United States
Broadridge New York, New York, United States
Caravelle Investment Fund New York, New York, United States
Future Architect Japan, Shinagawa
Grafton Capital England, London, United Kingdom
Hyderabad Angels Andhra Pradesh, Hyderabad, India
Minghong Wuliu Chengdu, China, Sichuan
NextGen Ventures Gelderland, Lunteren, The Netherlands
OPENAIR Equity Partners Kansas City, Missouri, United States
Science Foundation Ireland County Dublin, Dublin, Ireland
Stellar Kapital -
STIC International California, Palo Alto, United States
Sun Pacific California, Pasadena, United States
Wuxi NewForce Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MitoRx Therapeutics

25 Apr 2022 Harwell, Oxfordshire, United Kingdom

Sampling Human

Big Data
Health Care
Health Diagnostics
$2M12 Apr 2022 San Diego, California, United States

Celeris Therapeutics

Information Technology
Life Science
$3M10 Feb 2022 Graz, Steiermark, Austria


01 Dec 2021 Utrecht, Utrecht, The Netherlands

Maxwell Biosciences

Health Care
01 Oct 2021 Austin, Texas, United States

Embrace Prevention Care

01 Jun 2021 -


Health Care
01 May 2021 Palo Alto, California, United States

Celeris Therapeutics

Information Technology
Life Science
$472K28 Mar 2021 Graz, Steiermark, Austria

05 Mar 2021 Exeter, England, United Kingdom


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Longevitytech.fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: